By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ImmusanT, Inc. 

One Broadway
14th Floor
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-401-2154 Fax: n/a




Company News
ImmusanT, Inc. Banks $12 Million Series B 12/22/2014 7:08:41 AM
ImmusanT, Inc.’s Immunotherapy For Celiac Disease, Nexvax2, Selected As One Of Informa’s Top 10 Autoimmune/Anti-Inflammatory Projects To Watch 11/19/2014 5:04:11 PM
ImmusanT, Inc. Release: New Test In Celiac Disease Provides Powerful Tool For Diagnosis And Immune Monitoring 1/6/2014 9:52:33 AM
ImmusanT, Inc. Names Ferdinand E. Massari as Chief Medical Officer 9/9/2013 6:48:00 AM
ImmusanT, Inc. Release: New Approach to Celiac Testing Identifies More Patients at Risk 8/28/2013 9:31:39 AM
ImmusanT, Inc. Initiates Study at Joslin Diabetes Center to Investigate Relationship Between Celiac Disease and Type 1 Diabetes 8/6/2013 10:12:42 AM
ImmusanT, Inc.'s Epitope-Specific Immunotherapy for Celiac Disease Informs the Potential of Vaccines Against Other Autoimmune Diseases 4/22/2013 9:47:47 AM
New Insight Into Celiac Disease, Monash University, University of Leiden, and ImmusanT, Inc. Study 10/12/2012 7:32:19 AM
ImmusanT, Inc. Initiates Clinical Trials of Nexvax2 Therapeutic Vaccine for Celiac Disease 9/4/2012 10:57:45 AM
ImmusanT, Inc. Relocates Offices to State-of-the-Art Innovation Facility 8/16/2012 10:42:44 AM